180 Life Sciences Corp. (ATNF)
NASDAQ: ATNF · Real-Time Price · USD
0.8300
-0.0370 (-4.27%)
At close: Jun 27, 2025, 4:00 PM
0.8646
+0.0346 (4.17%)
After-hours: Jun 27, 2025, 5:09 PM EDT
180 Life Sciences Market Cap
180 Life Sciences has a market cap or net worth of $4.71 million as of June 27, 2025. Its market cap has increased by 214.20% in one year.
Market Cap
4.71M
Enterprise Value
1.18M
1-Year Change
214.20%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since June 27, 2017, 180 Life Sciences's market cap has decreased from $125.60M to $4.71M, a decrease of -96.25%. That is a compound annual growth rate of -33.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2025 | 5.00M | 38.89% |
| Dec 31, 2024 | 3.60M | 125.00% |
| Dec 29, 2023 | 1.60M | -76.81% |
| Dec 30, 2022 | 6.90M | -94.80% |
| Dec 31, 2021 | 132.70M | 169.72% |
| Dec 31, 2020 | 49.20M | -43.64% |
| Dec 31, 2019 | 87.30M | -42.45% |
| Dec 31, 2018 | 151.70M | 4.98% |
| Dec 29, 2017 | 144.50M | 15.05% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.51B |
| Johnson & Johnson | 366.18B |
| AbbVie | 327.76B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 277.24B |
| Abbott Laboratories | 240.24B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |